Progression of Early Atrophic Lesions

Part of paid clinical trials in Salt Lake City, Utah.

Sponsor
University of Utah
Study ID
NCT05959005
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
50 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • No intervention — OTHER
    There is no intervention.

Study Details

Early atrophic age-related macular degeneration (AMD) represents an important time window in the course of so far untreatable atrophic AMD, as patients typically experience only some degree of visual dysfunction, while being at significant risk for marked further loss of vision. To allow the precise evaluation of upcoming therapeutic interventions, a better understanding of the manifestation and variable disease progression is needed. This project aims to investigate refined tools to detect and monitor early atrophic AMD more accurately, including the impact on visual dysfunction and quality of life.

Key Dates

Start date
Oct 20, 2023
Status verified
Mar 2026
Primary completion
Jun 30, 2028
Completion
Dec 31, 2028

Study Design

Enrollment
125 participants (estimated)

Arms

  • Arm: Early GA lesions
    Non-interventional

Primary Outcome Measure

Change in geographic atrophy (GA) lesion size [ Time Frame: At months 36 from baseline ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
University of UtahSalt Lake CityUtah84132
Monika Fleckenstein
[email protected]
4352146967

Find similar trials in Salt Lake City, UT

By condition
Age-related macular degeneration
By specialty
OphthalmologyRetina
By research site
University of Utah· Salt Lake City, UT

Related Studies